Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Amortizatization of Intangibles (2016 - 2021)

BioRestorative Therapies (BRTX) has disclosed Amortizatization of Intangibles for 11 consecutive years, with $65041.0 as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Amortizatization of Intangibles rose 104.24% year-over-year to $65041.0, compared with a TTM value of $1.1 million through Dec 2021, down 11.31%, and an annual FY2021 reading of $1.1 million, down 11.31% over the prior year.
  • Amortizatization of Intangibles was $65041.0 for Q4 2021 at BioRestorative Therapies, down from $325964.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.8 million in Q1 2020 and bottomed at -$2.7 million in Q4 2019.
  • Average Amortizatization of Intangibles over 5 years is $114535.7, with a median of $210811.5 recorded in 2017.
  • Peak annual rise in Amortizatization of Intangibles hit 1185.52% in 2018, while the deepest fall reached 638.61% in 2018.
  • Year by year, Amortizatization of Intangibles stood at -$170602.0 in 2017, then plummeted by 638.61% to -$1.3 million in 2018, then crashed by 112.2% to -$2.7 million in 2019, then skyrocketed by 42.67% to -$1.5 million in 2020, then surged by 104.24% to $65041.0 in 2021.
  • Business Quant data shows Amortizatization of Intangibles for BRTX at $65041.0 in Q4 2021, $325964.0 in Q3 2021, and $325374.0 in Q2 2021.